A detailed history of Vident Advisory, LLC transactions in Sanofi stock. As of the latest transaction made, Vident Advisory, LLC holds 13,402 shares of SNY stock, worth $743,542. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,402
Previous 13,257 1.09%
Holding current value
$743,542
Previous $644 Million 0.93%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $6,581 - $7,302
145 Added 1.09%
13,402 $650 Million
Q1 2024

May 14, 2024

SELL
$45.75 - $52.48 $197,411 - $226,451
-4,315 Reduced 24.56%
13,257 $644 Million
Q4 2023

Feb 14, 2024

BUY
$43.13 - $54.79 $38,773 - $49,256
899 Added 5.39%
17,572 $874 Million
Q3 2023

Feb 21, 2024

SELL
$50.95 - $55.2 $45,804 - $49,624
-899 Reduced 5.12%
16,673 $894 Million
Q3 2023

Nov 14, 2023

BUY
$50.95 - $55.2 $849,489 - $920,349
16,673 New
16,673 $894 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $139B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.